Diaceutics Statistics

Total Valuation

Diaceutics has a market cap or net worth of GBP 106.02 million. The enterprise value is 90.40 million.

Market Cap	106.02M
Enterprise Value	90.40M

Important Dates

The last earnings date was Wednesday, December 18, 2024.

Earnings Date	Dec 18, 2024
Ex-Dividend Date	n/a

Share Statistics

Diaceutics has 84.47 million shares outstanding. The number of shares has decreased by -2.10% in one year.

Current Share Class	n/a
Shares Outstanding	84.47M
Shares Change (YoY)	-2.10%
Shares Change (QoQ)	+0.27%
Owned by Insiders (%)	23.53%
Owned by Institutions (%)	55.10%
Float	51.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.06
PB Ratio	2.74
P/TBV Ratio	4.38
P/FCF Ratio	64.64
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-31.78
EV / Sales	3.46
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	55.12

Financial Position

The company has a current ratio of 4.85, with a Debt / Equity ratio of 0.03.

Current Ratio	4.85
Quick Ratio	4.71
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	0.69
Interest Coverage	-85.33

Financial Efficiency

Return on equity (ROE) is -7.13% and return on invested capital (ROIC) is -6.75%.

Return on Equity (ROE)	-7.13%
Return on Assets (ROA)	-6.06%
Return on Capital (ROIC)	-6.75%
Revenue Per Employee	141,821
Profits Per Employee	-15,462
Employee Count	184
Asset Turnover	0.57
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +37.16% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+37.16%
50-Day Moving Average	121.78
200-Day Moving Average	120.81
Relative Strength Index (RSI)	70.63
Average Volume (20 Days)	133,099

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Diaceutics had revenue of GBP 26.10 million and -2.85 million in losses. Loss per share was -0.03.

Revenue	26.10M
Gross Profit	21.74M
Operating Income	-4.44M
Pretax Income	-3.75M
Net Income	-2.85M
EBITDA	-895,000
EBIT	-4.44M
Loss Per Share	-0.03

Full Income Statement

Balance Sheet

The company has 16.75 million in cash and 1.13 million in debt, giving a net cash position of 15.62 million or 0.18 per share.

Cash & Cash Equivalents	16.75M
Total Debt	1.13M
Net Cash	15.62M
Net Cash Per Share	0.18
Equity (Book Value)	38.74M
Book Value Per Share	0.46
Working Capital	21.62M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.77 million and capital expenditures -125,000, giving a free cash flow of 1.64 million.

Operating Cash Flow	1.77M
Capital Expenditures	-125,000
Free Cash Flow	1.64M
FCF Per Share	0.02

Full Cash Flow Statement

Margins

Gross margin is 83.30%, with operating and profit margins of -17.00% and -10.90%.

Gross Margin	83.30%
Operating Margin	-17.00%
Pretax Margin	-14.36%
Profit Margin	-10.90%
EBITDA Margin	-3.43%
EBIT Margin	-17.00%
FCF Margin	6.28%

Dividends & Yields

Diaceutics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.10%
Shareholder Yield	2.10%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Diaceutics has an Altman Z-Score of 8.45.

Altman Z-Score	8.45
Piotroski F-Score	n/a